나노플라즈모닉 바이오센서 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 구성요소, 용도, 재료 유형, 최종사용자, 기능성, 설치 유형, 솔루션

The global Nanoplasmonic Biosensors Market is projected to grow from $292.5 million in 2025 to $731.6 million by 2035, at a compound annual growth rate (CAGR) of 9.6%. The Nanoplasmonic Biosensors Market is driven by increasing demand for ultrasensitive diagnostics, growing research in precision medicine, and rising adoption of rapid point-of-care testing technologies. Recent research highlights that nanoplasmonic biosensors integrate nanomaterials with surface plasmon resonance (SPR) and localized surface plasmon resonance (LSPR) to enable highly sensitive detection of biomolecules at very low concentrations. Advances in gold and silver nanostructures, surface-enhanced Raman scattering, microfluidics, and miniaturized optical components are enabling applications in cancer detection, infectious disease diagnosis, biomarker monitoring, and personalized medicine.

The Type segment of the Nanoplasmonic Biosensors Market includes Localized Surface Plasmon Resonance (LSPR), Surface-Enhanced Raman Scattering (SERS), and Others. Localized Surface Plasmon Resonance (LSPR) dominated the market in 2025 due to its high sensitivity, label-free detection capabilities, rapid response, and suitability for detecting biomolecules and pathogens. Its integration with nanostructured materials and miniaturized biosensor platforms further supports adoption. Surface-Enhanced Raman Scattering (SERS) is expected to be the fastest-growing segment during the forecast period, driven by its ability to provide highly sensitive molecular fingerprinting, multiplex detection, and trace-level analysis. Increasing applications in medical diagnostics, food safety, environmental monitoring, and pharmaceutical analysis are expected to accelerate SERS adoption.

The End User segment of the Nanoplasmonic Biosensors Market includes Healthcare Facilities, Research Laboratories, Biotechnology Companies, Environmental Agencies, and Others. Healthcare Facilities dominated the market in 2025 due to increasing demand for rapid, sensitive, and minimally invasive diagnostic technologies for disease and biomarker detection. Biotechnology Companies are expected to be the fastest-growing segment during the forecast period, supported by increasing investment in biosensor development, drug discovery, molecular diagnostics, and personalized medicine. Growing adoption of nanoplasmonic technologies for high-throughput screening, biomolecular analysis, and real-time detection is expected to strengthen demand among biotechnology companies, while research laboratories will continue contributing to technological innovation and commercialization.

Geographical Overview

North America was the leading region in the Nanoplasmonic Biosensors Market in 2025, supported by advanced healthcare infrastructure, substantial investment in biotechnology and medical research, and strong capabilities in nanotechnology and biosensor development. The United States has been a major contributor, supported by leading pharmaceutical and biotechnology companies, academic research institutions, and established diagnostic networks. Increasing demand for highly sensitive and rapid detection technologies across medical diagnostics, environmental monitoring, food safety, and pharmaceutical research has supported the adoption of nanoplasmonic biosensors. Strong collaboration between research institutions and technology developers has also encouraged innovation in plasmonic sensing platforms.

Asia-Pacific is expected to be the fastest-growing region in the Nanoplasmonic Biosensors Market during the forecast period, driven by expanding healthcare infrastructure, increasing biotechnology and pharmaceutical research, rising demand for advanced diagnostic technologies, and growing government support for nanotechnology. China, Japan, India, and South Korea are expected to contribute significantly to regional expansion through investments in biosensor research, nanomaterials, medical diagnostics, and life-science technologies. Growing healthcare needs, increasing emphasis on early disease detection, and the expansion of research and development capabilities are expected to create further opportunities for nanoplasmonic biosensors across clinical, pharmaceutical, environmental, and food-safety applications.

Key Trends and Drivers

Integration of Nanoplasmonics With Portable Multiplexed Point-of-Care Diagnostics:

The Nanoplasmonic Biosensors Market is trending toward the integration of gold and silver nanostructures, surface-enhanced Raman spectroscopy (SERS), localized surface plasmon resonance (LSPR), microfluidics, and portable optical readout systems into compact point-of-care platforms. Recent developments are emphasizing multiplex detection of proteins, nucleic acids, pathogens, and cancer biomarkers from small biological samples. Hybrid plasmonic structures and AI-assisted analysis are also being explored to improve signal interpretation and enable automated diagnostics. Smartphone-compatible readers, flexible sensors, and lab-on-chip configurations are further reducing instrument size. These developments are positioning nanoplasmonic biosensors for rapid, sensitive, decentralized molecular testing and personalized diagnostics.

Demand for Ultra-Sensitive and Rapid Detection of Low-Concentration Biomarkers:

A key driver for the Nanoplasmonic Biosensors Market is the growing demand for early detection of diseases using extremely low concentrations of biomarkers. Nanoplasmonic structures amplify electromagnetic fields near metallic nanostructures, enabling highly sensitive detection of proteins, nucleic acids, pathogens, and other biomolecules that can be difficult to measure using conventional biosensors. This capability is particularly relevant for early cancer detection, infectious disease diagnostics, liquid biopsy, and precision medicine. The ability to provide rapid, potentially label-free, multiplexed analysis from small sample volumes is also encouraging development of decentralized testing platforms. Increasing emphasis on early diagnosis and personalized treatment is therefore supporting adoption of nanoplasmonic sensing technologies.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Component
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by Material Type
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Installation Type
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Localized Surface Plasmon Resonance (LSPR)
  • 4.1.2 Surface-Enhanced Raman Scattering (SERS)
  • 4.1.3 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Biosensor Chips
  • 4.2.2 Detection Kits
  • 4.2.3 Analyzers
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Optical
  • 4.3.2 Electrochemical
  • 4.3.3 Others
• 4.4 Market Size & Forecast by Component (2020-2035)
  • 4.4.1 Transducers
  • 4.4.2 Receptors
  • 4.4.3 Signal Processors
  • 4.4.4 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Medical Diagnostics
  • 4.5.2 Environmental Monitoring
  • 4.5.3 Food Safety
  • 4.5.4 Pharmaceuticals
  • 4.5.5 Biotechnology
  • 4.5.6 Others
• 4.6 Market Size & Forecast by Material Type (2020-2035)
  • 4.6.1 Gold Nanoparticles
  • 4.6.2 Silver Nanoparticles
  • 4.6.3 Copper Nanoparticles
  • 4.6.4 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Healthcare Facilities
  • 4.7.2 Research Laboratories
  • 4.7.3 Biotechnology Companies
  • 4.7.4 Environmental Agencies
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Label-Free Detection
  • 4.8.2 Multiplexing
  • 4.8.3 Real-Time Monitoring
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Installation Type (2020-2035)
  • 4.9.1 Portable
  • 4.9.2 Benchtop
  • 4.9.3 Others
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Custom Development
  • 4.10.2 Standardized Solutions
  • 4.10.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Component
    • 5.2.1.5 Application
    • 5.2.1.6 Material Type
    • 5.2.1.7 End User
    • 5.2.1.8 Functionality
    • 5.2.1.9 Installation Type
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Component
    • 5.2.2.5 Application
    • 5.2.2.6 Material Type
    • 5.2.2.7 End User
    • 5.2.2.8 Functionality
    • 5.2.2.9 Installation Type
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Component
    • 5.2.3.5 Application
    • 5.2.3.6 Material Type
    • 5.2.3.7 End User
    • 5.2.3.8 Functionality
    • 5.2.3.9 Installation Type
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Component
    • 5.3.1.5 Application
    • 5.3.1.6 Material Type
    • 5.3.1.7 End User
    • 5.3.1.8 Functionality
    • 5.3.1.9 Installation Type
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Component
    • 5.3.2.5 Application
    • 5.3.2.6 Material Type
    • 5.3.2.7 End User
    • 5.3.2.8 Functionality
    • 5.3.2.9 Installation Type
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Component
    • 5.3.3.5 Application
    • 5.3.3.6 Material Type
    • 5.3.3.7 End User
    • 5.3.3.8 Functionality
    • 5.3.3.9 Installation Type
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Component
    • 5.4.1.5 Application
    • 5.4.1.6 Material Type
    • 5.4.1.7 End User
    • 5.4.1.8 Functionality
    • 5.4.1.9 Installation Type
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Component
    • 5.4.2.5 Application
    • 5.4.2.6 Material Type
    • 5.4.2.7 End User
    • 5.4.2.8 Functionality
    • 5.4.2.9 Installation Type
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Component
    • 5.4.3.5 Application
    • 5.4.3.6 Material Type
    • 5.4.3.7 End User
    • 5.4.3.8 Functionality
    • 5.4.3.9 Installation Type
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Component
    • 5.4.4.5 Application
    • 5.4.4.6 Material Type
    • 5.4.4.7 End User
    • 5.4.4.8 Functionality
    • 5.4.4.9 Installation Type
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Component
    • 5.4.5.5 Application
    • 5.4.5.6 Material Type
    • 5.4.5.7 End User
    • 5.4.5.8 Functionality
    • 5.4.5.9 Installation Type
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Component
    • 5.4.6.5 Application
    • 5.4.6.6 Material Type
    • 5.4.6.7 End User
    • 5.4.6.8 Functionality
    • 5.4.6.9 Installation Type
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Component
    • 5.4.7.5 Application
    • 5.4.7.6 Material Type
    • 5.4.7.7 End User
    • 5.4.7.8 Functionality
    • 5.4.7.9 Installation Type
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Component
    • 5.5.1.5 Application
    • 5.5.1.6 Material Type
    • 5.5.1.7 End User
    • 5.5.1.8 Functionality
    • 5.5.1.9 Installation Type
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Component
    • 5.5.2.5 Application
    • 5.5.2.6 Material Type
    • 5.5.2.7 End User
    • 5.5.2.8 Functionality
    • 5.5.2.9 Installation Type
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Component
    • 5.5.3.5 Application
    • 5.5.3.6 Material Type
    • 5.5.3.7 End User
    • 5.5.3.8 Functionality
    • 5.5.3.9 Installation Type
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Component
    • 5.5.4.5 Application
    • 5.5.4.6 Material Type
    • 5.5.4.7 End User
    • 5.5.4.8 Functionality
    • 5.5.4.9 Installation Type
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Component
    • 5.5.5.5 Application
    • 5.5.5.6 Material Type
    • 5.5.5.7 End User
    • 5.5.5.8 Functionality
    • 5.5.5.9 Installation Type
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Component
    • 5.5.6.5 Application
    • 5.5.6.6 Material Type
    • 5.5.6.7 End User
    • 5.5.6.8 Functionality
    • 5.5.6.9 Installation Type
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Component
    • 5.6.1.5 Application
    • 5.6.1.6 Material Type
    • 5.6.1.7 End User
    • 5.6.1.8 Functionality
    • 5.6.1.9 Installation Type
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Component
    • 5.6.2.5 Application
    • 5.6.2.6 Material Type
    • 5.6.2.7 End User
    • 5.6.2.8 Functionality
    • 5.6.2.9 Installation Type
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Component
    • 5.6.3.5 Application
    • 5.6.3.6 Material Type
    • 5.6.3.7 End User
    • 5.6.3.8 Functionality
    • 5.6.3.9 Installation Type
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Component
    • 5.6.4.5 Application
    • 5.6.4.6 Material Type
    • 5.6.4.7 End User
    • 5.6.4.8 Functionality
    • 5.6.4.9 Installation Type
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Component
    • 5.6.5.5 Application
    • 5.6.5.6 Material Type
    • 5.6.5.7 End User
    • 5.6.5.8 Functionality
    • 5.6.5.9 Installation Type
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Thermo Fisher Scientific
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Agilent Technologies
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Bruker Corporation
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 HORIBA
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 PerkinElmer
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Bio-Rad Laboratories
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Danaher Corporation
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Shimadzu Corporation
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Malvern Panalytical
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Oxford Instruments
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Hitachi High-Tech Corporation
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 JEOL Ltd
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 ZEISS Group
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Endress+Hauser
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Mettler Toledo
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Waters Corporation
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Illumina
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Sartorius AG
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Roche Diagnostics
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Merck KGaA
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us